Similar articles

• [3,4-Dihydroxyphenyl alanine (DOPA)].

  Yatabe J, Sanada H. Yatabe J, et al. Nihon Rinsho. 2005 Aug;63 Suppl 8:380-3. Nihon Rinsho. 2005. PMID: 16149534 Review. Japanese. No abstract available.
• [3,4-Dihydroxyphenylalanine (DOPA)].

  Shigetomi S, Fukuchi S. Shigetomi S, et al. Nihon Rinsho. 1995 Mar;53 Su Pt 2:516-9. Nihon Rinsho. 1995. PMID: 8753294 Review. Japanese. No abstract available.
• [Purity criteria of L-Dopa (L-dihydroxyphenylalanine)].

  Jouin J, Saias E. Jouin J, et al. Ann Pharm Fr. 1972 Feb;30(2):139-44. Ann Pharm Fr. 1972. PMID: 5051261 French. No abstract available.
• Histochemistry of DOPA factors. II. The nature of the localizing-mechanisms in the DOPA-reaction.

  VAN DUIJN P. VAN DUIJN P. Acta Physiol Pharmacol Neerl. 1957 Oct;5(4):413-27. Acta Physiol Pharmacol Neerl. 1957. PMID: 13487340 No abstract available.
• DOPA in sympathetic nerve tissue--a possible source of serum DOPA in albino animals.

  Hansson C, Poulsen J, Rorsman H, Rosengren E. Hansson C, et al. Acta Derm Venereol. 1981;61(1):69-71. Acta Derm Venereol. 1981. PMID: 6164221